Weekly Rundown: In $1B deal, AbbVie buys psychedelic depression drug from Gilgamesh Oral GLP-1 data, srRNA therapies, and decentralized CAR T led drug discovery this week.

https://www.drugdiscoverynews.com/in-1b-deal-abbvie-buys-psychedelic-depression-drug-from-gilgamesh-16591